Clinical Trials Browser

Phase EARLY_PHASE1 × Cetuximab × 90 days × Clear all

NCT05816785 2026-04-22

Pilot Study of Imatinib Cetuximab Combo for H & N Cancer

Phase EARLY_PHASE1 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms